The drug's use with chemotherapy for adult patients with extensive-stage small cell lung cancer (SCLC) was approved by China's National Medical Products Administration, the Anglo-Swedish drugmaker said.from World News Headlines, Latest International News, World Breaking News - Times of India
No comments:
Post a Comment